help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on September 25, 2003
Molecular Endocrinology, doi:10.1210/me.2003-0280
Molecular Endocrinology Vol. 0, No. 2003 200302801-
doi:10.1210/me.2003-0280
Copyright © 2003 by the Endocrine Society.
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
17/12/2554    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by De Cesare, D.
Right arrow Articles by Sassone-Corsi, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by De Cesare, D.
Right arrow Articles by Sassone-Corsi, P.

Submitted on July 17, 2003
Accepted on September 18, 2003

Transcriptional Control in Male Germ Cells: General Factor TFIIA participates in CREM-dependent Gene Activation

Dario De Cesare1, Gian Maria Fimia1, Stefano Brancorsini1, Martti Parvinen1, and Paolo Sassone-Corsi1*

1 Institut de Génétique et de Biologie Moléculaire et Cellulaire; 1, rue Laurent Fries, 67404 Illkirch, Strasbourg, France; Department of Anatomy, University of Turku, 20520 Turku, Finland

* To whom correspondence should be addressed. E-mail: paolosc{at}igbmc.u-strasbg.fr.

Regulation of gene expression in haploid male germ cells follows a number of specific rules which differ from somatic cells. In this physiological context, transcriptional control mediated by the activator CREM represents an established paradigm. In somatic cells activation by CREM requires its phosphorylation at a unique regulatory site (Ser117) and subsequent interaction with the ubiquitous coactivator CBP. In testis, CREM transcriptional activity is controlled through interaction with a tissue-specific partner, ACT, which confers a powerful, phosphorylation-independent activation capacity. In addition to specialized transcription factors and coactivators, a variety of general factors of the basal transcriptional machinery, and their distinct tissue-specific isoforms, are highly expressed in testis, supporting the general notion that testis-specific gene expression requires specialized mechanisms. Here, we describe that CREM interacts with TFIIA, a general transcription factor that stimulates RNA polymerase II-directed transcription. This association was identified by a two-hybrid screen, using a testis-derived cDNA library, and confirmed by co-immunoprecipitation. The interaction is restricted to the activator isoforms of CREM and does not require Ser117. Importantly, CREM does not interact with TFIIA{tau}-ALF, a testis-specific TFIIA homolog. CREM and TFIIA are expressed in a spatially and temporally coordinated fashion during the differentiation program of germ cells. The two proteins also colocalize intracellularly in spermatocyte and spermatid cells. These findings contribute to the understanding of the highly specialized rules of transcriptional regulation in haploid germ cells.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2003 by The Endocrine Society